Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GSK Spin-Out NeRRe Raises £23m For NK Antagonists

Executive Summary

New cash will fund further clinical testing of NeRRe's two neurokinin receptor antagonists for cough and hot flashes.

Advertisement

Related Content

Venture Funding Deals: Takeda Ups Its Bet On Immuno-Oncology Play Maverick
VC Roundup: Infectious Disease Startup Snags $150m And Former Biogen CEO Scangos
Ogeda Seeks Financing After Successful Phase II For Non-Hormonal Menopause Drug
Millendo Raises $62m, Licenses AstraZeneca Drug
Biogen Idec buys analgesic developer Convergence for $200m+
New GSK Spin-Out Targets Hearing Loss

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC097974

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel